Objectives: To estimate the prevalence of anti-hepatitis A virus (anti-HAV) antibodies in serum samples from children and adolescents obtained at two clinical pathology laboratories in the city of Porto Alegre, south of Brazil, and to compare findings to those of a study carried out in the 1990s.
Introduction
Hepatitis A remains a major public health issue worldwide. Although its course is generally self-limited, the disease can vary widely in intensity, with severe forms sometimes occurring, and is a cause of significant morbidity in developed and developing countries alike. 1 Transmission occurs mainly through contact with infected individuals, by the fecal-oral a public laboratory that only serves patients within the Unified Health System framework (group 1), chosen to represent the lower socioeconomic strata; and a private laboratory, in which patients were screened according to a strategy meant to ensure enrollment of individuals from higher socioeconomic strata (group 2): patients were selected when they had paid the full cost of all tests performed outof-pocket, or when they were covered by high-cost family or individual health insurance plans, as suggested by the laboratory itself.
Both facilities provided residual aliquots of serum samples that would otherwise have been discarded. Subjects were enrolled consecutively.
A total of 501 subjects between the ages of 1 and 19 were included, from both facilities. Thirty-six subjects were excluded: two due to insufficient samples, nine due to duplicate enrollment, five due to insufficient age (< 1 year) and 20 who did not live in Porto Alegre. The final sample thus consisted of 222 subjects in group 1 and 243 in group 2.
Logistics
Each of the two laboratories assigned an employee to screen potential subjects and provide information required for the study. Samples taken from subjects who qualified after screening were frozen at -20 °C for later analysis of compliance with criteria for selection and inclusion. Control mechanisms for participant identification were established to prevent individuals from being included more than once in the sample. After compliance with the selection criteria was confirmed, subjects were included in the study sample according to the quota set for each age range.
All serum samples were tested for anti-HAV antibodies at a single laboratory, using commercially available electrochemiluminescence immunoassay kits (Elecsys Anti-HAV, Roche Diagnostics). Samples with an antibody concentration ≥ 20 UI/L were considered reactive (i.e.
indicative of prior contact with viral antigens) and those with antibody levels < 20 UI/L were considered negative.
Results were made available on the laboratory website and collected by the lead investigator (LSK) through a passwordprotected interface.
Ferreira et al. (1996)
One of the objectives of the present study is to compare the findings reported herein to those obtained by Ferreira et al. 14 in a cross-sectional study carried out in Porto Alegre in 1994. In this study, the authors assessed the seroprevalence of hepatitis A in children and adolescents (aged 1-19 years) of distinct socioeconomic strata and its association with socioeconomic level, age, and past history of hepatitis A infection. The laboratory from which samples were collected was used as an indicator of socioeconomic route, or through ingestion of contaminated water or food, particularly produce (fruits and vegetables) and bivalves. [2] [3] [4] Several characteristics of the hepatitis A virus (HAV), such as environmental stability (particularly when in association with organic matter) and resistance to low pH conditions and heat, favor waterborne and foodborne transmission of the virus, and also account for detection of the virus in background water and sewage samples. 3 Even in countries where hepatitis A is considered non-endemic, evidence suggests circulating HAV, possibly introduced by travelers, in a significant number of sewage samples. 5 Transmission by other routes, such as percutaneous or parenteral, has been reported, 3, 6 but occurs far less frequently due to the low viral load in the bloodstream. 7 Such factors as changes in the worldwide epidemiology of hepatitis A, reflecting the growth of a susceptible population, 8, 9 and the availability of effective vaccines 1, 2 have renewed interest in the disease, highlighting the need for a more precise understanding of this new reality so that prevention strategies may be defined. 10, 11 Serology studies conducted in Brazil have shown that the endemicity of hepatitis A is shifting in most of the country's regions, with significantly lower anti-HAV antibody seroprevalence rates among children and adolescents, [12] [13] [14] [15] particularly those in higher socioeconomic strata. 12, 14, 15 In Northern Brazil 12 and in some isolated communities in other regions, however, [16] [17] [18] prevalence is still significantly above the 65% national average (as estimated by a study conducted in 1996-1997). 12 In the mid-1990s, Ferreira et al. 14 status. The 199 subjects in the low socioeconomic status group were recruited from a public hospital that provided care exclusively within the Unified Health System, whereas the 188 subjects from the high socioeconomic status group were selected from a sample of patients who sought testing at a private laboratory and paid for all tests in full and out of pocket. As in the present study, anti-HAV antibody testing was performed at a single laboratory using commercially available enzyme immunoassay kits (Cobas Core anti-HAV ® , Roche). 14 
Statistical analysis
Sample size was calculated by age range for a minimum statistical power of 80% and a significance level (α) of 0.05, using as a basis the differences in anti-HAV prevalence by socioeconomic group reported elsewhere in the literature. 12 Sample size was estimated as follows for each of the defined age strata: a) age 1-5, 39 subjects; b) age 6-10, 26 subjects; c) age 11-15, 102 subjects; d) age 16-20, 65 subjects, for a total of 232 patients per group (464 subjects overall).
Categorical data were expressed as absolute and relative frequencies (counts and percentages), with their respective 95% confidence intervals (95%CI), based on binomial distribution. Chi-square or Fisher's exact test were used as necessary for comparisons between strata. In order to estimate the size of differences, percent changes (%Δ) and their respective 95%CIs were calculated. Prevalence ratios were calculated to measure the differences between anti-HAV prevalence rates in the present study as compared to those found by Ferreira et al. 14 for each age range. The trend line shown in Figure 1 represents the linear relationship between the differences of both studies, stratified by age range. The direct standardization method was used to enable between-group comparison of overall anti-HAV positivity rates, taking into account the age distribution of the Rio Grande do Sul state population. 19 Data were analyzed in the SPSS 17.0 software package (SPSS Inc., Chicago, IL).
The significance level was set at 0.05.
Ethical considerations
The study protocol was approved by the Research Ethics Committees of Hospital de Clínicas de Porto Alegre (judgment number 06/612) and Grupo Hospitalar Conceição (judgment number 028/07). The authors signed a commitment to maintain subject confidentiality and use any data obtained solely for the purposes of the present study. 
Results

Socioeconomic status*/
In the present study, overall anti-HAV seroprevalence The greatest susceptibility rates to the hepatitis A virus were found predominantly in the 1-to-4 and 5-to-9 age ranges of group 1, with susceptibility rates of 80.6 and 74.2% respectively, and in the 15-to-19-year subgroup of group 2, with a rate of 70.9% (Table 1) .
Comparison of our results against those obtained by
Ferreira et al., 14 a study which used similar patient selection criteria, showed no statistically significant difference in anti-HAV prevalence rates among low socioeconomic status subjects in the 1-to-4, 10-to-14, and 15-to-19 age groups.
Conversely, in the 5-to-9 age group, the anti-HAV positivity rate in the present sample was 25.8% -a significant decline from the 52.7% rate reported by Ferreira et al. 14 (p = 0.03) ( Table 1) .
Discussion
Hepatitis A is ubiquitous, but endemicity patterns vary widely between countries and even between different regions of a single country, due to the diversity of hygiene and sanitation conditions, which play a major role in determining the age of exposure to hepatitis A virus and, consequently, disease severity. 1, 8 Although children generally develop a more benign form of the disease, severe clinical manifestations may occur. 20 In a recent study of 33 children and adolescents treated at the Hospital de Clínicas de Porto Alegre for acute liver failure, hepatitis A accounted for 39% of cases (13 of 33) and 69% of deaths (nine of 13). 21 A study conducted in the state of Minas Gerais, Brazil, by Mesquita et al. 22 found that, in a sample of 10 patients who received liver transplants due to fulminant hepatic failure, the etiology of liver failure was determined in only five, and was found to be related to hepatitis A in two. 22 In Brazil, hepatitis A is part of the national list of notifiable diseases, 23 volunteers recruited from the community and from several schools in Porto Alegre), with a mean seroprevalence rate of 55.7%. After stratifying by age and socioeconomic status, the authors found a significantly higher prevalence of anti-HAV across all age ranges in the low socioeconomic status group, except among older subjects. 12 In the present study, the overall seroprevalence of anti-HAV was statistically similar in groups 1 and 2 (37.6 and 46.1%, respectively, p = 0.08). In group 1, the percentage rate of anti-HAV positivity increased with advancing age, which is to be expected with infectious diseases that rely on environmental exposure for transmission. 13 The converse distribution of anti-HAV prevalence in group 2 -with higher rates in the youngest age groups -is not consistent with the findings of prior Brazilian studies 12, 14, 15 or international investigations 24 (Table 1) .
On comparison with the results obtained by Ferreira et al., 14 the significantly lower anti-HAV reactivity rate in the 5-to-9 age range in group 1 of the present study suggests that HAV transmission is currently in decline in Porto Alegre. We believe the similar anti-HAV prevalence rate found in the 1-to-4 age range is likely due to the sum of two factors: prior exposure to the hepatitis A virus and immunization of some individuals in the study sample. As for the similar frequency of anti-HAV reactivity found in the 10-to-14 and 15-to-19-year groups, our working hypothesis is that it is due to childhood infection ( Table 1) . Comparison of group 2 in both studies showed a significantly higher anti-HAV prevalence in the younger age groups of the present study -far in excess of those reported by Ferreira et al. 14 (p < 0.001). In the 15-to-19 age range, there was no statistically significant difference between studies (p = 0.15) ( Table 1 ).
The prevalence ratios of anti-HAV reactivity in children of both studies show that anti-HAV antibodies occurred roughly 18 times more frequently in the 1-to-4-year age group in the present study, eight times more often in the 5-to-9 age range, five times more frequently in the 10- (Table 1) . Gradual improvement in sanitation and health conditions reduces, but does not eliminate, transmission of hepatitis A, and promotes a shift in the occurrence of hepatitis A infection to individuals of higher socioeconomic status, producing a greater impact on public health 1 and fostering outbreaks that can be prolonged and refractory to control efforts. 8, 9 In this context, the main concern lies in preventing symptomatic and, above all, severe cases of hepatitis A, such as those leading to acute liver failure. Routine immunization could quickly bring infection rates under control and decrease the burden of the disease on the health system, both through its individual efficacy and by inducing herd immunity. 29 Although the purpose of this study was not to justify inclusion of the hepatitis A vaccine in the Brazilian Ministry of Health immunization schedule, we believe the results obtained may constitute an argument in favor of this recommendation, or may prompt a future cost-effectiveness study that can provide inputs for planning of disease control strategies.
These results suggest that the endemicity of hepatitis A in Porto Alegre has declined over the past decade, and that susceptibility to the disease is higher in children and adolescents, particularly those of lower socioeconomic status.
In support of this hypothesis, it bears noting that the hepatitis A vaccine has yet to be added to the immunization schedule of the Brazilian National Immunization Program 25 ;
it is only available at Special Immunobiology Referral Centers (to specific population groups) 26 or at private immunization clinics. The Brazilian Society of Pediatrics has recommended that children be vaccinated against hepatitis A since 1998, 27 at first depending on "possibility and availability" and, since 2005, unconditionally, at age 12 months, followed by a booster dose 6 months later. 28 We believe that, due to its high cost, administration of the hepatitis A vaccine has been restricted to individuals with higher purchasing power and, therefore, indicated to children with a lower likelihood of past HAV infection. We have also analyzed data on use of the hepatitis A vaccine in Porto Alegre provided by a private immunization clinic in the city. In 1995, approximately 0.1% of patients seen at the clinic received the hepatitis A vaccine, 30% of whom were children between the ages of 1 and 4. In 1998, the vaccine was administered to roughly 4% of patients seen at the clinic, 46% of whom were in the 1-to-4 age group. By 2007, the year in which the study was performed, approximately 11% of patients in the clinic were receiving the hepatitis A vaccine -52% in the 1-to-4 age range (Cunha J, unpublished data). These percentages are even more striking when one considers
